1-O-CinnamoylglucoseCAS# 40004-96-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 40004-96-4 | SDF | Download SDF |
PubChem ID | 133556475 | Appearance | Powder |
Formula | C15H18O7 | M.Wt | 310.3 |
Type of Compound | Phenylpropanoid | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | [(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (E)-3-phenylprop-2-enoate | ||
SMILES | C1=CC=C(C=C1)C=CC(=O)OC2C(C(C(C(O2)CO)O)O)O | ||
Standard InChIKey | CJGRGYBLAHPYOM-BPEFQWATSA-N | ||
Standard InChI | InChI=1S/C15H18O7/c16-8-10-12(18)13(19)14(20)15(21-10)22-11(17)7-6-9-4-2-1-3-5-9/h1-7,10,12-16,18-20H,8H2/b7-6+/t10-,12-,13+,14-,15+/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
1-O-Cinnamoylglucose Dilution Calculator
1-O-Cinnamoylglucose Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.2227 mL | 16.1134 mL | 32.2269 mL | 64.4538 mL | 80.5672 mL |
5 mM | 0.6445 mL | 3.2227 mL | 6.4454 mL | 12.8908 mL | 16.1134 mL |
10 mM | 0.3223 mL | 1.6113 mL | 3.2227 mL | 6.4454 mL | 8.0567 mL |
50 mM | 0.0645 mL | 0.3223 mL | 0.6445 mL | 1.2891 mL | 1.6113 mL |
100 mM | 0.0322 mL | 0.1611 mL | 0.3223 mL | 0.6445 mL | 0.8057 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 1-O-p-Coumaroylglucose
Catalog No.:BCN0470
CAS No.:7139-64-2
- 5-endo-Hydroxyborneol
Catalog No.:BCN0469
CAS No.:68738-10-3
- 6,4'-Dihydroxy-5,7-dimethoxyflavanone
Catalog No.:BCN0468
CAS No.:6951-57-1
- p-O-Farnesylcoumaric acid
Catalog No.:BCN0467
CAS No.:939769-47-8
- (±)-Cleroindicin F
Catalog No.:BCN0466
CAS No.:94535-01-0
- Flindulatin
Catalog No.:BCN0465
CAS No.:521-44-8
- Tabernaecorymbosine A
Catalog No.:BCN0464
CAS No.:1262306-81-9
- Alpinigenine
Catalog No.:BCN0463
CAS No.:14028-91-2
- 2,4-Dihydroxy-6-methoxy-3,5-diprenylacetophenone
Catalog No.:BCN0462
CAS No.:123999-38-2
- 4,5-Dioxodehydroasimilobine
Catalog No.:BCN0461
CAS No.:82644-81-3
- 3,8-Di-O-methylellagic acid 2-O-(5'-O-acetyl)arabinofuranoside
Catalog No.:BCN0460
CAS No.:365540-09-6
- 5-exo-Hydroxyborneol
Catalog No.:BCN0459
CAS No.:32751-73-8
- 1,4-Dihydro-1-methyl-4-oxonicotinamide
Catalog No.:BCN0472
CAS No.:769-49-3
- Acrotrione
Catalog No.:BCN0473
CAS No.:2349327-31-5
- Polypodine B 20,22-acetonide
Catalog No.:BCN0474
CAS No.:159858-85-2
- 2',3'-Dehydromarmesin
Catalog No.:BCN0475
CAS No.:28664-60-0
- (±)-8-Gingerol
Catalog No.:BCN0476
CAS No.:77398-92-6
- Ferruginoside C
Catalog No.:BCN0477
CAS No.:213991-03-8
- 2,4,6-Trihydroxy-3-prenylacetophenone
Catalog No.:BCN0478
CAS No.:27364-71-2
- Kokusaginine
Catalog No.:BCN0479
CAS No.:484-08-2
- 4-(Acetoxymethyl)phenyl glucoside
Catalog No.:BCN0480
CAS No.:188290-72-4
- Isorengyol
Catalog No.:BCN0481
CAS No.:101489-38-7
- Stigmalactam
Catalog No.:BCN0482
CAS No.:289499-72-5
- [6]-Gingerol
Catalog No.:BCN0483
CAS No.:39886-76-5
UPLC-PDA-TOFMS based chemical profiling approach to rapidly evaluate chemical consistency between traditional and dispensing granule decoctions of traditional medicine combinatorial formulae.[Pubmed:20138455]
J Pharm Biomed Anal. 2010 Aug 1;52(4):468-78.
In the present study, an ultra performance liquid chromatography coupled with photo-diode array detector and time-of-flight mass spectrometry (UPLC-PDA-TOFMS) based chemical profiling approach to rapidly evaluate chemical consistency between traditional and dispensing granule decoctions of traditional medicine combinatorial formulae was proposed and validated using San-Huang-Xie-Xin-Tang (SHXXT) as a model combinatorial formula. Two different kinds of decoctions, namely traditional decoction: water extract of mixed three constituent herbs of SHXXT, and dispensing granules decoction: mixed water extract of each individual herbs of SHXXT, were prepared. Batches of these two kinds of decoction samples were subjected to UPLC-PDA-TOFMS analysis, the datasets of t(R)-m/z pairs, ion intensities and sample codes were processed with supervised orthogonal partial least squared discriminant analysis (OPLS-DA) to holistically compare the difference between these two kinds of decoction samples. Once a clear classification trend was found in score plot, further statistics was performed to generate S-plot, in which the variables (t(R)-m/z pair) contributing most to the difference were clearly depicted as points at the two ends of "S", and the components that correlate to these ions were regarded as the most changed components during decocting of combinatorial formula. The identities of the changed components can be identified by comparing the mass/UV spectra and retention times with those of reference compounds and/or tentatively assigned by matching empirical molecular formulae with those of the known compounds published in the literatures. Using the proposed approach, global chemical difference was found between traditional and dispensing granule decoctions, and berberine, palmatine, epiberberine, baicalin, wonogoside, 2-O-golloyl-1-O-Cinnamoylglucose and emodin were identified as the most changed components during decocting SHXXT. It is suggested that this newly established approach could be used practically for the evaluation of chemical consistency between traditional and dispensing granule decoctions of traditional medicine combinatorial formulae.